Added to YB: 2025-09-04
Pitch date: 2025-09-02
BIOG-B.ST [neutral]
BioGaia AB (publ)
-6.01%
current return
Author Info
Lind Research provides institutional grade investment research in the Nordics. Sign up for the newsletter.
Company Info
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
Market Cap
SEK 10.7B
Pitch Price
SEK 104.00
Price Target
N/A
Dividend
6.55%
EV/EBITDA
22.35
P/E
37.24
EV/Sales
6.97
Sector
Biotechnology
Category
growth
Discovery Report: Watchlist add - Biogaia (OM: BIOGB)
BIOG-B.ST watchlist: Swedish probiotic co riding gut health trend. SEK 1.44B revenue, SEK 423M EBIT past 12mo. Pediatrics 75% rev (mid-single digit growth), Adults +20%. Margins compressed due to shift from distributor to direct sales for long-term scalability. New chairman Mauricio Graber insider buying. Valuation still high, waiting for more pessimism.
Read full article (1 min)